Using TPC1 cells, a human thyroid cancer cell line expressing a CCDC6-RET fusion protein (Ishizaka et al., 1989), we performed a series of drug screens to identify insights into drug sensitivity and resistance. The gene discussed is RET; the disease is thyroid gland carcinoma.